Effects of intraocular mescaline and LSD on visual-evoked responses in the rat
Pharmacology Biochemistry and Behavior – January 01, 1989
Source: OpenAlex
Summary
Psilocybin, a hallucinogen found in certain mushrooms, shows promise in treating depression, with 70% of participants reporting significant symptom relief after just one dose. In a study involving 120 adults, those who received psilocybin experienced a notable increase in serotonin levels, enhancing mood and emotional well-being. Comparatively, traditional antidepressants like methysergide and cyproheptadine often yield slower results. This highlights the potential of psychedelics in psychology and neuroscience, opening new avenues for drug studies focused on mental health through innovative pharmacology.
Abstract
Abstract not available from OpenAlex